These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24052020)

  • 1. End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.
    Pyo J; Won Kim K; Jacene HA; Sakellis CG; Brown JR; Van den Abbeele AD
    Clin Cancer Res; 2013 Dec; 19(23):6566-77. PubMed ID: 24052020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL).
    Luminari S; Biasoli I; Versari A; Rattotti S; Bottelli C; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Franceschetto A; Boccomini C; Franceschetti S; Salvi F; Raimondo FD; Carella AM; Micol Q; Balzarotti M; Musto P; Federico M
    Ann Oncol; 2014 Feb; 25(2):442-7. PubMed ID: 24412823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
    Trotman J; Fournier M; Lamy T; Seymour JF; Sonet A; Janikova A; Shpilberg O; Gyan E; Tilly H; Estell J; Forsyth C; Decaudin D; Fabiani B; Gabarre J; Salles B; Van Den Neste E; Canioni D; Garin E; Fulham M; Vander Borght T; Salles G
    J Clin Oncol; 2011 Aug; 29(23):3194-200. PubMed ID: 21747087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
    Bishu S; Quigley JM; Bishu SR; Olsasky SM; Stem RA; Shostrom VK; Holdeman KP; Paknikar S; Armitage JO; Hankins JH
    Leuk Lymphoma; 2007 Aug; 48(8):1548-55. PubMed ID: 17701586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review.
    Adams HJA; Nievelstein RAJ; Kwee TC
    Ann Hematol; 2016 Jan; 95(1):11-18. PubMed ID: 26576560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis.
    Burggraaff CN; de Jong A; Hoekstra OS; Hoetjes NJ; Nievelstein RAJ; Jansma EP; Heymans MW; de Vet HCW; Zijlstra JM
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):65-79. PubMed ID: 30141066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
    Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K
    Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.
    Adams HJ; Kwee TC
    Ann Hematol; 2016 Apr; 95(5):695-706. PubMed ID: 26931115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study.
    Tychyj-Pinel C; Ricard F; Fulham M; Fournier M; Meignan M; Lamy T; Vera P; Salles G; Trotman J
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):408-15. PubMed ID: 24435770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT predictive role in follicular lymphoma.
    Lopci E; Zanoni L; Chiti A; Fonti C; Santi I; Zinzani PL; Fanti S
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):864-71. PubMed ID: 22354449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
    Qiao W; Zhao J; Wang C; Wang T; Xing Y
    Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
    Wong-Sefidan I; Byrtek M; Zhou X; Friedberg JW; Flowers CR; Zelenetz AD; Dawson KL; Reid E
    Leuk Lymphoma; 2017 Apr; 58(4):809-815. PubMed ID: 27562750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
    Kato K; Izutsu K; Nishikori M; Shibayama H; Maeda Y; Yoshimura K; Tateishi U; Miyamoto T; Matsuda Y; Ishikawa J; Rai S; Takahashi T; Yamauchi T; Matsumura I; Akashi K; Kanakura Y; Suzumiya J
    Int J Hematol; 2024 Jun; 119(6):677-685. PubMed ID: 38519820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.
    Dixon JG; Dimier N; Nielsen T; Zheng J; Marcus R; Morschhauser F; Evens AM; Federico M; Blum KA; Shi Q
    Br J Haematol; 2022 Jul; 198(2):333-337. PubMed ID: 35491747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of patients with early-stage follicular lymphoma staged with
    Ng SP; Khor R; Bressel M; MacManus M; Seymour JF; Hicks RJ; Wirth A
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):80-86. PubMed ID: 30083824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of
    Han S; Choi JY
    Breast Cancer Res; 2020 Oct; 22(1):119. PubMed ID: 33129348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
    Lu Z; Lin M; Downe P; Chong S; Ling S
    Ann Nucl Med; 2014 Oct; 28(8):805-11. PubMed ID: 25008291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
    Kostakoglu L; Goy A; Martinelli G; Caballero D; Crump M; Gaidano G; Baetz T; Buckstein R; Fine G; Fingerle-Rowson G; Berge C; Sahin D; Press O; Sehn L
    Leuk Lymphoma; 2017 Feb; 58(2):372-381. PubMed ID: 27339738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.